Endothelial Cell Therapy for the Acute and Chronic Liver Disease
Seminars in Liver Disease · 2026-03 · 46 (01) · 077-088
DOI: 10.1055/a-2841-9824 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 09.04.2026. Verfasst von Dilnar Mahmut und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Gastroenterology, Department of Medicine, Center for Regenerative Medicine, Boston University Chobanian and Avedisian School of Medicine, …. Hauptthemen laut MEDLINE: Liver Diseases, Endothelial Cells, Liver, Stem Cell Transplantation. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Endothelial cell dysfunction and loss are key drivers of acute and chronic liver disease, underscoring a critical unmet need for liver vascular–targeted therapies. Liver sinusoidal endothelial cells are specialized endothelial cells that form a fenestrated microvascular niche regulating hepatocyte metabolism, immune homeostasis, and hepatic stellate cell activation. Repopulating this niche through transplantation of primary liver sinusoidal endothelial cells, endothelial progenitor cells, induced-pluripotent stem cell–derived liver sinusoidal endothelial cells, or engineered endothelial cells delivered within biomaterial aims to restore microvascular architecture, reestablish supportive angiocrine signaling, attenuate fibrosis, and promote liver regeneration. This review summarizes the biological rationale for endothelial cell–based therapy, compares cell sources and engineering strategies, evaluates cell delivery and engraftment approaches, and synthesizes preclinical evidence demonstrating therapeutic benefits across diverse animal models of liver injury. Finally, we highlight key translational challenges and propose future directions to accelerate the clinical development of endothelial cell–based therapies for liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Gastroenterology, Department of Medicine, Center for Regenerative Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, United States.
Förderung
- NIH HHS
- NCATS NIH HHS
Zitieren
APA
Mahmut, D., & Gouon-Evans, V. (2026). Endothelial Cell Therapy for the Acute and Chronic Liver Disease. Seminars in Liver Disease, 46(01), 077-088. https://doi.org/10.1055/a-2841-9824
Vancouver
Mahmut D, Gouon-Evans V. Endothelial Cell Therapy for the Acute and Chronic Liver Disease. Seminars in Liver Disease. 2026;46(01):077-088. doi:10.1055/a-2841-9824
BibTeX
@article{Mahmut2026,
author = {Mahmut, Dilnar and Gouon-Evans, Valerie},
title = {Endothelial Cell Therapy for the Acute and Chronic Liver Disease},
journal = {Seminars in Liver Disease},
year = {2026},
volume = {46},
number = {01},
pages = {077--088},
doi = {10.1055/a-2841-9824}
}
EUVIMED